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Abstract
Background: The Agency for Healthcare Research and Quality (AHRQ) launched the EvidenceNOW Initiative to
rapidly disseminate and implement evidence-based cardiovascular disease (CVD) preventive care in smaller primary
care practices. AHRQ funded eight grantees (seven regional Cooperatives and one independent national evaluation)
to participate in EvidenceNOW. The national evaluation examines quality improvement efforts and outcomes for
more than 1500 small primary care practices (restricted to those with fewer than ten physicians per clinic). Examples of
external support include practice facilitation, expert consultation, performance feedback, and educational materials and
activities. This paper describes the study protocol for the EvidenceNOW national evaluation, which is called Evaluating
System Change to Advance Learning and Take Evidence to Scale (ESCALATES).
Methods: This prospective observational study will examine the portfolio of EvidenceNOW Cooperatives using both
qualitative and quantitative data. Qualitative data include: online implementation diaries, observation and interviews at
Cooperatives and practices, and systematic assessment of context from the perspective of Cooperative team members.
Quantitative data include: practice-level performance on clinical quality measures (aspirin prescribing, blood pressure
and cholesterol control, and smoking cessation; ABCS) collected by Cooperatives from electronic health records (EHRs);
practice and practice member surveys to assess practice capacity and other organizational and structural characteristics;
and systematic tracking of intervention delivery. Quantitative, qualitative, and mixed methods analyses will be
conducted to examine how Cooperatives organize to provide external support to practices, to compare effectiveness
of the dissemination and implementation approaches they implement, and to examine how regional variations and
other organization and contextual factors influence implementation and effectiveness.
Discussion: ESCALATES is a national evaluation of an ambitious large-scale dissemination and implementation effort
focused on transforming smaller primary care practices. Insights will help to inform the design of national health care
practice extension systems aimed at supporting practice transformation efforts in the USA.
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Background
The Agency for Healthcare Research and Quality (AHRQ)
launched the EvidenceNOW Initiative in 2015 to promote
delivery of evidence-based cardiovascular disease (CVD)
preventive care in smaller primary care practices with lim-
ited resources and experience with quality improvement
(QI), and to expand the nation’s capacity to rapidly trans-
late evidence into practice. AHRQ funded seven regional
Cooperatives spanning 12 states in the USA. Each
Cooperative received a 3-year grant to create a health
practice extension infrastructure to implement interven-
tions aimed at decreasing cardiovascular risk for their pa-
tient populations within approximately 250 primary care
practices, each with less than ten clinicians and with lim-
ited quality improvement capacity. Along with providing
active external support, the Cooperatives will evaluate
practice improvement efforts. In the call for proposals,
AHRQ required use of measures that are common across
the Cooperatives, including measures of CVD clinical
quality and practice capacity outcomes. Cooperatives are
required to share these data with a national evaluation
team, which AHRQ funded separately.
This paper describes the study protocol for the Eviden-
ceNOW national evaluation, called Evaluating System
Change to Advance Learning and Take Evidence to Scale
(ESCALATES) which aims to comprehensively evaluate
the dissemination and implementation (D&I) approaches
of the seven Cooperatives to generate overarching, cross-
Cooperative findings. This work will inform future large-
scale D&I efforts and expand the understanding of the
characteristics of effective practice facilitation and regional
extension services for practice improvement.
QI in primary care practice
In hospitals and health systems with substantial re-
sources, large QI initiatives have been shown to improve
care quality by creating communities of learning that
change behavior on a large scale [1–3]. The majority of
people in the USA, however, receive care in smaller
practices (with less than ten clinicians) [4] and without
external support for change. More than half of primary
care clinicians in the USA practice in a setting of five or
fewer clinicians and about one-third in practices with
less than two clinicians [5]. Smaller practices face sub-
stantial challenges in transforming their approach to
care delivery, including greater time constraints, fewer
staff, and fewer resources to support change than larger
practices [6–10]. Few small practices have the time, re-
sources, or expertise to develop QI capacity, and typic-
ally these practices need external support [11, 12] which
may include performance feedback and benchmarking
[13–15], practice facilitation or coaching [16–19], aca-
demic detailing or expert consultation [20–25], and par-
ticipating in learning collaboratives [26–29]. In the
context of the rapid pace of practice transformation in
the USA, primary care practices, particularly smaller ones,
can become overwhelmed and experience change fatigue,
which further slows QI progress by creating tension and
conflict, burnout, turnover, and resistance to change [10].
External organizations may be able to assist practices with
QI, and improve adherence to evidence-based guidelines
[11]. One type of external organization that might help
with this is the practice care health extension [30, 31]. The
concept of extension is dynamic and the most commonly
recognized extension system is a rural or agricultural
extension as seen in the USA and internationally. The
practice extension, like the agricultural extension, might
use an administrative structure, in partnership with
local communities, to bring about change in practices
through a combination of education, problem solving
support, technical advice, and resources to help prac-
tices make improvements and proactively respond to fu-
ture developments.
Cardiovascular disease and the ABCS
Many people do not receive guideline-concordant health
care. This is true even for relatively low cost treatments
such as aspirin prescribing, blood pressure and choles-
terol control, and smoking cessation (the ABCS), each of
which can significantly reduce risk of cardiovascular dis-
ease (CVD) [32, 33]. CVD is the leading cause of death
in the USA, with stroke or heart disease contributing to
one out of every three deaths [34]. Primary risk factors
for CVD (high blood pressure, high cholesterol, smok-
ing, obesity) are often preventable or treatable [34].
While increasing rates of ABCS is known to significantly
reduce risk for CVD, the overall uptake of these effective
preventive services is low, even among a clinic’s high-
risk patients [32, 33]. Nationally, only 53 % of people
with documented hypertension have blood pressures at
or below target levels [34], only one-third of people with
elevated cholesterol are adequately managed by, e.g.,
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taking a statin, and less than 25 % of the individuals who
smoke receive assistance with quitting.
A recent study on pay-for-performance incentives in
small practices with electronic health records (EHRs)
found that baseline ABCS rates were low in small pri-
mary care practices for aspirin therapy, blood pressure
control, and smoking cessation [35]—a situation that is
even worse among clinics caring for the poor and for ra-
cial/ethnic minority populations [36, 37]. If the ABCS ser-
vices were consistently delivered in primary care, the
burden of CVD would be greatly reduced [38, 39]. To ad-
dress this quality gap, in 2011, the Department of Health
and Human Services (DHHS) and the Center for Disease
Control and Prevention (CDC) launched the Million
Hearts Initiative for Medicare and Medicaid Services
(CMS) members/patients. It seeks to prevent one million
heart attacks and strokes by 2017 by empowering individ-
uals to make healthy choices and by improving delivery of
ABCS services [32, 33]. The EvidenceNOW initiative is fo-
cused on improving the delivery of ABCS services among
a large cohort of smaller primary care practices.
As the national evaluation of EvidenceNOW, ESCA-
LATES will accomplish the following aims:
1. Evaluate the overall EvidenceNOW initiative by
engaging regional Cooperatives in harmonizing
measures, working together to collect similar
qualitative and quantitative data, identifying lessons
learned, and fostering rapid-cycle learning;
2. Identify practice, organization, and contextual
factors associated with meeting ABCS performance
goals at baseline (prior to intervention);
3. Identify the intervention strategies that are most
effective in improving ABCS performance goals/
targets and practice capacity in relation to practice,
organization, and contextual factors, and learn why
some strategies are more effective by integrating
qualitative and quantitative data; and
4. Engage, rapidly disseminate, and evaluate the impact
of disseminating actionable findings to key external
stakeholders.
The ESCALATES evaluation is a collaboration among
investigators at Oregon Health and Science University,
University of Texas School of Public Health, Rutgers
Robert Wood Johnson Medical School, HealthPartners,
Case Western Reserve University, University of Michigan,
and Lehigh Valley Health Network.
Methods/design
Study design
ESCALATES is a prospective mixed methods observa-
tional comparative study using a range of qualitative and
quantitative data collection approaches to accomplish
the study aims (see Table 1). The ESCALATES study is
informed by the Learning Evaluation approach in that
we will analyze clinical relevant outcome measures that
do double-duty as performance measures for practices,
thereby fostering learning for practices; we collect and
analyze real-time quantitative and qualitative data on
important contextual factors, and the goal is to foster
cross-Cooperative learning from process and outcome
data [40]. Table 2 list key elements of the evaluation.
Study setting and population
EvidenceNOW Cooperatives will support practices in 12
US states and are each partnering with local collabora-
tors (e.g., regional extension centers, quality improvement
organizations) to engage smaller primary care practices in
their regions. At the Cooperative level, the study sample
includes the following regions: Midwest: Illinois, Indiana
and Wisconsin (Principal Investigator (PI): Kho); New
York City (PI: Shelley); North Carolina (PI: Cykert);
Northwest: Washington, Oregon and Idaho (PI: Parchman);
Oklahoma (PI, Duffy); Southwest: Colorado and New
Mexico (PI: Dickinson); and Virginia (PI: Kuzel). The ES-
CALATES evaluation will include the approximately 1,500
primary care practices, their staff members, and patients
across the Cooperatives.
Evaluation framework
The ESCALATES evaluation uses the Consolidated
Framework for Implementation Research (CFIR) [41] and
the Practice Change Model (PCM) to guide the study de-
sign [42]. The CFIR is a highly organized explanatory
framework that identifies factors that potentially influence
implementation success, organized across five domains:
characteristics of the intervention (e.g., complexity); outer
setting (e.g., external policies and incentives); inner setting
(e.g., leadership engagement, compatibility); characteristics
of individuals (e.g., knowledge and beliefs); and process
(e.g., planning). The PCM is an empirically-derived, dy-
namic conceptual model for how change happens in pri-
mary care practices. The PCM complements and extends
the CFIR by differentiating motivation and capacity or re-
sources for change, emphasizing the importance of inter-
dependencies that manifest among the contextual and
environmental factors influencing intervention effective-
ness, and expanding the CFIR concept of “inner setting”
through delineation of the factors that shape motivation.
Together, the PCM and CFIR provide a robust set of
frameworks for evaluating the array of factors which dir-
ectly inform measurement and that may influence the
D&I interventions used by the Cooperatives.
Data collection
In the ESCALATES evaluation, data will be collected at
the Cooperative and practice levels. Table 2 shows the
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Table 1 Data Sources
Description Level Source of data Type of data Frequency
Cooperative grant proposals Cooperative’s initial plan for implementation Cooperative-level Collected by ESCALATES team with
Cooperatives assistance
Qualitative Pre-grant award
Other documents Documents Cooperative’s develop
(ex: recruitment materials, PF curricula, etc.)
Cooperative-level Collected by ESCALATES team with
Cooperatives assistance
Qualitative Throughout study period
Online diaries Online journal; approximately 5-13 people per
Cooperative; document implementation
experiences
Cooperative-level Online, interactive communication platform Qualitative Post 2x mo.; Start-up to
post-implementation
Cooperative site visits To observe and understand how interventions
are implemented
Cooperative-level Fieldnotes Qualitative Annually years 2 and 3
Sustainability site visits To understand how/which parts of the D&I
infrastructure is sustained beyond the life
of the grant
Cooperative-level Fieldnotes Qualitative Year 4
Semi-structured interviews To understand barriers/facilitators of specific
aspects of implementation; experience with
intervention; mechanisms of change




Proportion of patients meeting ABCS and data
source (e.g. EHR, chart review)
Aggregated by Practice Medical Record (EHR extraction/chart reviews);
collected by Cooperatives; shared with ESCALATES
Quantitative Baseline through end of
study; Quarterly
Stratified ABCS measures Proportion of patients stratified by gender, age,
race, ethnicity, insurance type meeting ABCS
Aggregated by practice Medical record (EHR extraction); collected by
Cooperatives; shared with ESCALATES
Quantitative Baseline through end of
study; Quarterly
Practice survey Practice capacity (CPCQ), EHR adoption,
practice demographics (internal and
external characteristics)
Practice-level Survey (online/paper); completed by office
manager or designated clinic leader; collected
by Cooperatives; shared with ESCALATES
Quantitative Baseline, post-intervention,
6 m follow up
Practice member survey Practice capacity (AR), focus on patients’
needs and resources, practice readiness
to change, burnout, clinician attitudes
towards new guidelines
Aggregated by Practice Survey (online/paper) completed by a majority of
practice members (target > 70 %); collected by
Cooperatives; shared with ESCALATES
Quantitative Baseline, post-intervention,
6 m follow up
External support
intervention tracking
Type of external support provided, date of
contact, mode of contact, duration of
contact, practice engagement assessment




Strategies in place to improve ABCS,
assessment of the extent to which
strategies are implemented
Practice-level Collected by Cooperatives; shared with ESCALATES Quantitative At least baseline and
post-intervention
Practice site visits To observe and understand how interventions
are implemented
Cooperative-level Fieldnotes Qualitative 60 practice site visits
across years 2 and 3
Patient pathways To observe patients exposure to/experience
with intervention
Practice-level Observation by evaluation team during
site visits
Qualitative Observe five–ten patient
visits at each practice visit
Context assessment To understand the contextual factors of
implementation
Cooperative-level Interviews with Cooperative key stakeholders Qualitative Annually with two–three

















The ESCALATES team will collect Cooperative docu-
ments that are important to understanding the interven-
tions they propose, the modifications they make to their
plans, and the partnerships they develop to carry out
their work. This includes, but is not limited to, grant ap-
plications, documents that establish changes to study
and intervention design, training materials for Coopera-
tive staff, meeting agendas and minutes, and educational
materials for practices.
Online diaries
Each Cooperative will identify at least five diary-keepers
who will participate in an online diary to document ex-
periences during project development and evolution, in-
cluding practice engagement, recruitment, and providing
external support for implementation. The use of online
diaries as a qualitative data collection method has been
described in detail elsewhere [43]. Briefly, each team will
have a private online diary space to post entries in a blog
type format. Cooperatives will be encouraged to make
diary entries at least twice a month. Only diary-keepers at
a particular Cooperative and evaluation team members
will be able to view entries from that Cooperative, and we
shall maintain strict external confidentiality about the in-
formation posted within each Cooperative. The ESCA-
LATES team will read entries weekly and interact with
Cooperative diary-keepers via the online diary to encour-
age frequent posting.
Site visits
The ESCALATES team will visit each Cooperative annu-
ally to facilitate collaborative work and to fully under-
stand the D&I approaches they are implementing and
their lessons learned. The site visits will last approxi-
mately 2 days each year, and ESCALATES team mem-
bers will meet with each Cooperative’s project personnel
including the research team, practice facilitators, coa-
ches, consultants, and other partners. The ESCALATES
team will observe Cooperative intervention strategies,
foster discussions on implementation experiences, and
observe interactions among partnering institutions and
with individual practices. In year 4 of the study, after
funding for the Cooperatives has ended, the ESCA-
LATES team will conduct an additional site visit that
will focus on assessing the sustainability of the network
infrastructure.
Cooperative semi-structured interviews
During site visits, the ESCALATES team will conduct
five–ten semi-structured interviews with key stake-
holders from the Cooperative. Interviews will focus on
filling knowledge gaps about the intervention strategies
being tested, understanding the experiences of partner-
ing stakeholders, the mechanisms by which interven-
tions are believed to change outcomes, and the factors
that affect or explain implementation experiences. Inter-
views will follow a guide to be refined for use with each
Cooperative and each key stakeholder. Interviews will
last 40–60 min and will be audio recorded and profes-
sionally transcribed.
Practice-level data collection
The ESCALATES team will work with Cooperatives to
harmonize collection of key practice-level outcome mea-
sures required by AHRQ (e.g., ABCS measures, practice
capacity). As described below, ABCS data collection will
require extraction from practices’ EHRs and practice
capacity measures will require self-report or survey data
collection methods. The ESCALATES team will also en-
gage Cooperatives in a collaborative process to prioritize
and harmonize the collection of additional measures that
align with our goals.
ABCS data
Cooperatives will provide practice-level ABCS data to the
ESCALATES team, as specified in Table 3. Cooperatives
will collect data from participating practices’ EHRs using a
range of data extraction methods (e.g., programming,
manual chart review). ABCS measures will be collected at
baseline—before interventions begin—and quarterly
through the end of each Cooperative’s study. Cooperatives
will also contribute practice-level ABCS data stratified by
gender, race, ethnicity, age, and insurance type to allow for
the examination of disparities.
Practice surveys
In addition to ABCS clinical quality measures, informa-
tion about practice characteristics is needed as well as
practice capacity for change, a key outcome measure. Each
Table 2 Key elements of the ESCALATES evaluation
- Multi-level focus on Cooperatives and practices
- Longitudinal data collection over three years
- Baseline and quarterly data collection on cardiovascular measures
- Collection of practice capacity outcome at baseline, and two time
points post-intervention
- Extensive qualitative data collection through document review,
interviews, online diaries, and observation
- Detailed external support and practice implementation tracking
- Measurement of implementation science conceptual markers
- Assessments of change in small, medium-sized family medicine
practices
- Formative and summative evaluation assessments
- Mixed methods integration of the quantitative and qualitative results
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Cooperative will administer surveys to collect practice
level data on characteristics and capacity using descriptive
questions. The “practice survey” (PS), will collect data on
practice organization and infrastructure (e.g., size, owner-
ship, staffing, EHR capacity). This survey will include the
change process capacity questionnaire (CPCQ) [44, 45],
which is a measure of both a practice’s capacity for QI
and the strategies used to improve. One person in the
practice (preferably a practice leader) will complete the
PS. The second survey, the “practice member question-
naire” (PMQ), will be administered to practice mem-
bers and include a measure of organizational culture
and capacity using the adaptive reserve [10, 46–49]
scale. In addition, the ESCALATES team will work with
Cooperatives to identify high-priority measures to
understand implementation, as informed by the CFIR
and PCM frameworks. The PS and PMQ surveys will
be administered by Cooperatives at baseline, immedi-
ately post-intervention, and 6-month post-intervention.
The ESCALATES team will work with Cooperatives to
help ensure a high response rate.
External support and practice implementation tracking
It is important for this evaluation to track characteristics
of the interventions delivered to practices, including the
type and intensity of external support interventions re-
ceived, along with changes that practices implement to
increase ABCS delivery. The ESCALATES team will
work with Cooperatives to establish methods (e.g., prac-
tice facilitator contact logs, collaborative (onsite) or
webinar attendance records) to track the type, frequency,
duration and mode of external support provided to prac-
tices and their engagement with it. Data collection re-
lated to external support will continue throughout each
Cooperative’s active intervention period, which will vary
by Cooperative. The ESCALATES team will also work
with Cooperatives to develop mutually agreeable
methods to track and share the change strategies prac-
tices implement to improve ABCS (e.g., registries, stand-
ing orders) and the extent to which these changes are
implemented within these practices.
Practice site visits
The ESCALATES team will also conduct practice site
visits. We will purposively select a sample of 40–60
practices using both qualitative and quantitative data to
do so. The ESCALATES team will develop a matrix that
ranks practices by ABCS outcomes at baseline (from
high to low), and will also include percent change in
ABCS over study period, Cooperative, ownership, and
characteristics relevant to the region within the
Cooperative (e.g., rural, underserved) where relevant.
The ESCALATES team will use this matrix of quantita-
tive information along with qualitative implementation
data to select a maximum variation sample of high and
low performing practices, approximately six–eight per
Cooperative. We will conduct preliminary analyses based
on the first two–three visits and use this information to
revise sample selection criteria as needed. This iterative
process of selecting practices, collecting data, and using
this information to refine sampling decisions will continue
Table 3 Clinical quality outcome measures
Measure Description (CMS e-quality measure, National Quality Forum measure) Source of data
Proportion of patients in a
practice at risk for CVD receiving
guideline-concordant care (ABCS)
Data will be reported for the
practice overall, and stratified
by gender, race, ethnicity,
age, and insurance type.
Patients within each practice who are: 18 years of age and
older who were discharged alive for acute myocardial infarction,
coronary artery bypass graft or percutaneous coronary
interventions in the 12 months prior to the measurement
period, or who had an active diagnosis of ischemic vascular
disease during the measurement period, and who had
documentation of use of aspirin or another antithrombotic
during the measurement period (Aspirin, A, CMS164v4, NQF0068)
Medical Record (EHR extraction/chart
reviews); collected by Cooperatives;
shared with ESCALATES
18-85 years of age who had a diagnosis of hypertension and
whose blood pressure was adequately controlled (<140/90 mmHg)
during the measurement period (Blood Pressure, B, CMS165v4, NQF0018)
High-risk adult patients aged > = 21 years who were previously
diagnosed with or currently have an active diagnosis of clinical
atherosclerotic cardiovascular disease; OR adult patients aged
> =21 years with a fasting or direct Low-Density Lipoprotein
Cholesterol (LDL-C) level > = 190 mg/dL; OR patients aged
40-75 years with a diagnosis of diabetes with a fasting or direct
LDL-C level of 70-189 mg/dL; who were prescribed or are already
on statin medication therapy during the measurement year
(Cholesterol Management, C, CMS347)
18 years and older, who were screened for tobacco use 1or more times
within 24 months AND who received cessation counseling intervention
if identified as a tobacco user (Smoking, S, CMS138v4, NQF0028)
*ABCS data will be collected from baseline through end of Cooperatives' three-year study. Cooperatives will share data with our ESCALATES team quarterly
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until variations in outcomes are adequately explained as
indicated by theme saturation.
The ESCALATES team will work with Cooperative
teams to invite practices to participate. Practices will re-
ceive a monetary fee for their time and participation. A
multi-person team will spend 1–2 days in a practice inten-
sively observing how ABCS care is delivered and conduct
interviews (scheduled to minimize disruption) with prac-
tice members to understand their experiences with exter-
nal support and their efforts to implement interventions
aimed at increasing delivery of ABCS. Interviews will also
identify practice, organization and contextual factors influ-
encing implementation. Interviews guides and observation
templates will be refined and tailored to each practice and
to each member based on information from online diaries,
Cooperatives, member role, and site visit preparation calls
with practice members.
Patient pathways
At each site visit, study staff will conduct five–ten pa-
tient pathways [50]. Patient pathways are designed to ob-
serve patients’ exposures to and experiences with how
the practice has implemented changes. Front desk staff
will alert a field researcher when a patient meeting sam-
pling criteria checks-in. The field researcher will ask the
doctor and patient for permission to observe the visit. If
both agree, the field researcher will follow the patient
through the visit (e.g., intake, visit with clinician, check-
out), being unobtrusive and making brief notes to be
written up later as fieldnotes.
Analytic strategy
This study aims to answer the following research
questions:
Cross-sectional research questions (baseline):
1. What are the rates of meeting ABCS performance
goals/targets among a large sample (>1500) of small-
and medium-size primary care practices?
2. What are the practice, organizational and contextual
factors associated with varying degrees of meeting
ABCS performance goals/targets at baseline (prior to
implementing any intervention)?
Longitudinal Research Questions:
1. What are the types of intervention strategies
(e.g. receiving different external support)
implemented by Cooperatives, and how do they
develop infrastructure for delivering these
strategies to practices?
2. Across practices, what are the effects of
intervention strategies on change in practice
processes and ABCS performance measures and
practice capacity (e.g., CPCQ, adaptive reserve)
over time, and how do these intervention
strategies interact with practice, organization, and
contextual factors to explain the observed change?
3. Across practices, why are some intervention
strategies more effective than others?
4. What are the explanations for variation in
outcomes across Cooperatives on ABCS and
practice capacity outcomes (e.g., how do high and
low performing practices differ, and how do
intervention strategies and intensity, practice and
organization characteristics contribute to these
differences)?
Below, we describe the analytic strategy we will use to
answer study research questions:
Cross-sectional research questions (baseline)
At baseline (pre-intervention), the ESCALATES team
will determine the overall rates of meeting ABCS
performance targets across Cooperatives. These data
will provide nationally representative estimates of
ABCS delivery rates among small- to medium-size
primary care practices, identify the current status of
ABCS target attainment, and determine how much
room for improvement is available over the study
period.
The ESCALATES team will then evaluate the prac-
tice, organizational and contextual factors associated
with ABCS performance prior to implementing an
intervention. Initial analyses will be descriptive, using
data visualization methods. The principal outcome of
interest is the proportion of eligible patients meeting
ABCS performance goals for each practice (i.e., con-
tinuous values from 0 to 1). We will perform univari-
able and multivariable beta regressions with variable
dispersion [51]. Beta regression models are common
in analysis of rates and proportions. We will use sur-
vey measures informed by the CFIR and PCM to con-
struct independent variable selection models that help
to identify relevant variables among many potential
candidates to achieve better interpretability and un-
cover previously unknown relationships in the data.
Variable selection for the proposed beta regression
model will be performed using a regularization tech-
nique [52] similar to the adaptive LASSO (regression
analysis). The ESCALATES team will select the final
model based on the Bayesian information criterion
(BIC) by choosing the tuning parameter with the low-
est BIC value because regularization-type methods
with a BIC-type tuning parameter selector, under cer-
tain criteria, have been shown to do consistent vari-
able selection [53].
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Longitudinal research questions
Identifying and distinguishing Cooperatives’ intervention
approaches
A central aspect of Cooperatives’ interventions involves
developing the infrastructure needed to rapidly deliver
external support to approximately 250 practices. The
ESCALATES team will analyze qualitative data to
characterize the specifics of each Cooperative’s external
support strategy and to create typologies that distinguish
interventions and characterize the infrastructure Coop-
eratives develop to support practices. Typologies are a
system for categorizing Cooperatives and their partici-
pating practices into groups based on a set of salient
characteristics. Groupings will be quantified and become
variables in subsequent quantitative analyses. This mixed
methods procedure is to converge the data using data
transformation so that a quantitative analysis can be used
based on quantifying the qualitative findings. To do this,
the ESCALATES team will analyze qualitative data using a
grounded theory approach [54–56] to characterize the fac-
tors that emerge as barriers/facilitators to implementation
(e.g., practice, context/environmental, and intervention
characteristics), how and by whom external support is de-
livered and the factors that affect this, and what changes
practices implement and why. We will make comparisons
across Cooperatives, paying particular attention to factors
leading to a Cooperative excelling or struggling in
response to the intervention. We will create matrices to
display data for comparative analyses as suggested by
Miles and Huberman [57]. As the ESCALATES team de-
velops initial classifications, these will be shared with Co-
operatives as a form of “member checking,” a qualitative
research verification step accomplished by asking key in-
formants to validate study findings [58–61]. This analytic
strategy will result in rich interpretive summaries of each
Cooperative’s intervention, particularly with respect to
core features of intervention strategies and other charac-
teristics the ESCALATES team identify as important to
D&I. Summaries and matrices will lead to the develop-
ment of a series of typologies that categorize and trans-
form important aspects of the Cooperatives and their
interventions into quantitative variables. For example, ex-
ternal support (e.g., practice facilitation, expert consult-
ation), mode of intervention (e.g., face-to-face, email,
phone), frequency (number) and duration (length) of con-
tacts might be made into a composite variable to represent
intensity of external support for use in subsequent quanti-
tative analyses.
Effect of intervention strategies on change in outcomes
Examining the effectiveness of external support interven-
tions will involve estimating differences in ABCS and
practice capacity outcomes for different intervention strat-
egies received by practices engaged in each Cooperative,
as well as differences in practice implementation. Inter-
vention strategies will be compared to each other and/or
to a control group of practices using a differences-in-
differences (DID) approach [62]. The DID model is a
flexible approach which can accommodate different study
designs Cooperatives may propose to evaluate their own
interventions. Conceptually, cluster-randomized designs,
interrupted time studies, and step-wedge designs can be
nested within the DID framework. The primary require-
ments are the inclusion of baseline (pre-intervention) data
and data from a control group. In addition to examining
the effectiveness of intervention typologies as assigned, we
will also conduct sub-analyses that include differing levels
of fidelity to quality improving strategies practices use.
The DID approach has been frequently used by health ser-
vices researchers and economists to account for potential
secular effects and changing policies that would affect
both intervention and control groups over time, while
adjusting for potential confounders [7, 63–68].
The overall analysis to assess intervention strategies
on ABCS performance can be considered as shown in
the equation
Y it ¼ f αþ
Xr
j¼1






where: Yit represents clinic i’s performance on an out-
come measure (i.e., one of the ABCS measures, mean
adaptive reserve score) at time t,; Ij represents a dummy
variable (intervention strategy received variable de-
scribed above) taking a value of 1 if the clinic was in-
volved in intervention j and zero otherwise; and τj is a
dummy variable taking a value of 1 if the observation
took place after the intervention and 0 otherwise, and f
represents a general function that captures our intent to
model performance through a beta regression for ABCS
measures and linear regression for practice capacity out-
comes. The coefficient α is an overall intercept repre-
senting average baseline performance for all clinics; βj
represents the incremental baseline performance differ-
ential between clinics in typology j, and δ represents the
change in performance pre- and post-intervention, for
all clinics. The θj coefficients are the coefficients of
interest, as they capture the relative performance im-
provement for each group using intervention typology r.
The qualitative analyses described above will produce r
variables (e.g., high, medium, low intensity support strat-
egy) (r lying somewhere between 3 and 6). In this model,
control groups serve as the reference. This equation can
be adapted to include additional dummy variables for
each time period or a continuous variable to capture lin-
ear time trends as well as fixed effects (equivalent to
dummy variables) for practices.
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The ESCALATES team will use two-way fixed effects
models (i.e., a fixed effect for each practice and for each
time period) so the results do not rest on some of the
stricter assumptions required for random effects models.
However, we will also conduct analyses by introducing a
practice random intercept and slope to allow interven-
tion effects to vary across practices in the different study
arms. This approach explicitly models different cluster-
ing levels (e.g. Cooperative, region, practice) [63]. In this
case, rather than treating the practice as a nuisance fac-
tor, this approach allows each practice to respond differ-
ently over time to the intervention and allows the
ESCALATES team to estimate those changes and study
the heterogeneity of effects due to variation in context
across Cooperatives and differences across practices
within each Cooperative.
The analyses described above will be conducted for
each ABCS measure. In addition, ESCALATES will pro-
duce a model that pools all measures and uses measure-
specific fixed effects, which will allow for an assessment
of an “overall” effect of the interventions.
Assessing contextual factors and heterogeneity of
intervention effects
To assess heterogeneity of intervention effects, ESCA-
LATES will identify factors associated with substantial
improvement for some practices and lack of change or
worsening performance for others. For instance, the ES-
CALATES team may observe that practices receiving the
external support strategy of data feedback/benchmarking
resulted in significantly improved ABCS performance
measures over time as compared to a group of practices
receiving expert consultation or a control group of prac-
tices. On further analysis of the effect of type of practice
(moderator) on the observed association, however, the
ESCALATES team may find that practices affiliated with
large health systems showed greater improvements in
ABCS measures than independent practices. Thus, this
effect modification analysis is designed to capitalize on
the large sample size and diversity of practices and sev-
eral different intervention strategies that will be tested
by Cooperatives to identify heterogeneity of ABCS mea-
sures and practice capacity measures of association
across levels of modifying variables. Another key variable
of this analysis involves the fidelity with which practices
implement QI tools to address ABCS. Data on imple-
mentation fidelity will be collected using the external
support/practice implementation tracking data. ESCA-
LATES will create meaningful categories of this variable
to include in the modification analysis, such as practices
that implement QI tools consistently and to a high de-
gree of fidelity will likely perform better at improving
ABCS and practice capacity than those that do not, even
when both groups of practices receive the same external
support.
This analysis will extend the DID models proposed
above by testing individual moderators with a three-way
interaction of intervention group, time point and poten-
tial moderator. Our choice of variables to include will be
based on theory and on triangulation with qualitative
findings. Potential moderators include practice character-
istics, as significantly associated with ABCS outcomes at
baseline, and contextual factors that emerge during imple-
mentation. Moderators may be identified through surveys
or qualitative data. Moderators identified through qualita-
tive data will be quantified whenever possible. In addition
to testing individual moderators, we will consider a com-
posite moderator, which may more strongly moderate the
effect of the intervention strategies on ABCS outcomes
than any single moderator. Specifically, ESCALATES will
create a combined moderator that is developed as a
weighted combination of individual selected moderators
to identify for which practices different intervention strat-
egies may be preferred. Combining moderators has been
shown to exhibit a larger moderator effect size than any
individual moderator [67]. We will develop and evaluate a
composite moderator using the parametric approach de-
veloped by Kraemer [69], which constructs a composite
moderator from a weighted average of moderators that
are weighted to maximize the correlation between the
outcome difference between randomly paired practices
and the average of the two values of the moderator
variable.
In addition to these quantitative analyses of heterogen-
eity, we will also conduct qualitative analyses to evaluate
the multilevel contextual factors that could affect either the
interpretation of the results of each analysis, or that might
be useful for others attempting to replicate or reinvent in-
terventions in different times or situations [70, 71]. These
analyses will use multiple data sources across multiple
levels (from the practice and health care system, the inter-
vention/evaluation team, and the local and national policy
context), and will attempt to include diverse stakeholder
perspectives of the most important contextual factors at
critical points in the project/intervention, to help under-
stand what happened here and why, and what someone else
would need to know to transport/re-invent what was
learned here in a different time and place. These analyses
will enhance the external validity of ESCALATES findings.
Summative explanations for variation in outcomes across
Cooperatives
To analyze why some intervention strategies are more
effective than others, the ESCALATES team will analyze
data among a group of high and low performing prac-
tices, using the same steps for qualitative data analysis
described above. Data for this analysis will include
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fieldnotes, interviews, and external support/practice im-
plementation tracking data which will allow us to estab-
lish what the practices implemented to improve ABCS
delivery. Importantly, the qualitative team will be
blinded to a practice’s status as a high or low performer
during the data collection and analysis process. The
qualitative team will identify mechanisms of practice
change with regard to ABCS performance, the factors
that influence a practice’s ability to implement or not
implement change, and practice members’ experiences
with their respective Cooperative’s intervention. At this
stage, the qualitative team will bring in other data
sources to make sense of the characteristics that distin-
guish practices. The end product will be a table of 40–
60 practices and the factors or elements the qualitative
team identifies as potentially important to practice
change and improvement, and whether this element is
present or absent for a practice. Next, the quantitative
team will add practice performance to this table. A joint
display will be created for a mixed methods analysis
comparing the high and low performance practices in
terms of qualitative findings and quantitative results. In
order to distill a clear understanding of the factors asso-
ciated with successful implementation, the qualitative
team will use this information to conduct a deviant case
analysis [72], examining in greater detail practices not
conforming to our initial interpretation of what distin-
guishes low and high performing practices. As a final
step, the full ESCALATES team will reflect on findings
to fully identify the range of factors and characteristics
vital to successful implementation of ABCS among
which types of smaller practices and the key elements of
external support required for practice improvement and
for developing ongoing QI capacity.
Trial status
The ESCALATES team has engaged the seven Coopera-
tives in the data harmonizing process, conducted one
site visit with each Cooperative, and are working to re-
fine a common set of measures and procedures for data
collection. Cooperatives’ recruitment of practices is in
progress. The start of baseline data collection and imple-
mentation of interventions will vary by Cooperative with




The EvidenceNOW Initiative is a unique national part-
nership between Cooperatives in seven distinct and di-
verse geographic regions of the USA who are each
bringing together leaders and creating health care exten-
sion services with the credibility, expertise, relationships,
and capacity to engage a large number of small- to
medium-size primary care practices in rapid dissemin-
ation and implementation of CVD prevention guidelines.
These types of primary care demonstration projects,
pilot studies, and internally driven improvement efforts
are typically not rigorously evaluated; when they are,
they are not evaluated in a way that includes the evi-
dence needed to know both that an innovation worked
and how it worked so that lessons learned about imple-
mentation can be translated to other settings. The
national-level ESCALATES evaluation addresses these
gaps via an overarching mixed methods evaluation. Key
elements of our evaluation are summarized in Table 2
above. Quantitative data will help us identify the most ef-
fective combinations of external support strategies for rap-
idly disseminating and implementing evidence into practice
for various practice types, contexts, and organizational
characteristics. Qualitative data from Cooperatives and se-
lected practices will help us understand why and how those
combinations are effective. At several points in the evalu-
ation, these two databases will be merged to form a mixed
methods analysis. The multiple data sources and perspec-
tives that inform our evaluation, and our focus on context-
ual factors that explain cross-collaborative variations in
ABCS and practice capacity will provide an unusually high
level of external, as well as internal validity.
Limitations
This protocol has several limitations. First, it may not be
possible to harmonize measures across Cooperatives to
the extent desired to optimize evaluation. This may be
especially true for ABCS performance measures. Should
this occur, the ESCALATES team has two strategies for
addressing this limitation: (1) harmonize data for as
many Cooperatives/practices as possible and conduct
the analyses proposed on a subset of practices, and (2)
treat each Cooperative as a case to conduct a compara-
tive case analysis which uses Cooperative reported out-
comes and synthesizes these findings with qualitative
data. Second, some practices may be lost to follow-up
for various reasons, while others may experience diffi-
culties collecting study data as proposed. Such differen-
tial reasons for attrition may create biases in the sample.
To mitigate this problem, the ESCALATES team will
use a tracking mechanism to record practices that drop
out and to identify practices that participate in the inter-
vention but were unable to provide data. ESCALATES
will follow-up with Cooperatives to identify the reasons
data are not provided by practices. For practices that
drop out, ESCALATES will have baseline demographic
data (from the PS) and we will compare these practices
with those remaining in the study to assess possible
biases. Third, analysis of disparities is dependent on
Cooperatives’ ability to extract consistent disparities data
at the practice level from practices. The ESCALATES
Cohen et al. Implementation Science  (2016) 11:86 Page 10 of 13
team will work with Cooperatives to extract EHR data to
assess disparities, including race/ethnicity, age, and gen-
der. ESCALATES will learn why these data are or are
not able to be extracted, ESCALATES will understand
how practices generated these data (e.g., patient report)
and, if these data are not available, ESCALATES will ask
participating practices to make estimates via the PS.
Although these data may not be 100 % accurate, in the
absence of better data, they can provide information on
whether a practice has a predominant minority or a pre-
dominant Spanish-speaking patient panel, for example.
The ESCALATES team can then use these data as a
“crude” measure of disparity.
Impact
A national effort of this scale and focus is unparalleled
and offers a tremendous opportunity to learn how to
build a national extension infrastructure and close the
evidence-to-clinical practice gap among primary care
practices. Learning evaluations such as ESCALATES,
where innovators, evaluators, and funders work collabora-
tively and learn from each other, are critical to under-
standing the impact these transformative initiatives have
on practice and patient outcomes [40]. The findings from
this evaluation have the potential to inform the develop-
ment of a national health care extension system in the
USA, to contribute to what is known about how best to
rapidly disseminate and implement evidence into primary
care practices, and to contribute to a richer understanding
of the complex set of practice organizational and cultural
factors from which capacity and related quality-related
outcomes emerge.
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